Study shows BIOTRONIK Neuro's remote monitoring led to high therapy use and lower explant rates, sets new device management standard.

Recently published research in Neuromodulation1 has unveiled that BIOTRONIK Neuro's utilization of remote monitoring combined with remote programming has resulted in notable outcomes. The study conducted in LAKE OSWEGO, Ore., on Jan. 5, 2026, highlights that the continuous remote monitoring has led to significantly increased rates of therapy utilization. As a result, this approach has contributed to a considerable decrease in explant rates, showcasing the effectiveness of the technology. This highlights the significant impact of incorporating technology into healthcare, with the study revealing a clear correlation between remote monitoring and improved patient outcomes.